Among patients with STEMI and multivessel disease, the benefit of complete revascularization over culprit-lesion only PCI was consistent irrespective of the investigator-determined timing of nonculprit lesion intervention.
Findings do not support the contention that patients undergoing cardiac catheterization should have their beta blockers or ACE inhibitors suspended.
Researchers demonstrated that left ventricular unloading with transcatheter aortic valve replacement is associated with acute improvements in right ventricular function and right ventricular-pulmonary artery coupling.
Subcutaneous implantable cardioverter-defibrillator is a feasible option not only in patients without structural but also in a selected patient collective with structural heart disease.
Implantation of the self-expanding Biovalve transcatheter heart valve for the treatment of severe aortic stenosis was deemed to be safe, with clinical outcomes similar to those of other first-generation devices designed for the same indication.
Multiphase assessment of the neo left ventricular outflow tract may be superior to end-systolic estimates to determine the risk for LVOT obstruction with transcatheter mitral valve replacement.
The rate of complications and in-hospital mortality was found to be high in patients undergoing transcutaneous lead extraction for implantable device-related infections.
Three-dimensional transesophageal echocardiography does not require contrast media, which may be particularly beneficial in patients with impaired renal function.
A novel voltage-independent high-density mapping display can identify the functional substrate for ventricular tachycardia during sinus rhythm and guide targeted ablation.
Endocardial left atrial appendage closure performed at high volume centers had the lowest in-hospital complications and 30-day readmissions, but with higher hospitalization costs.
